Johnson & Johnson said ​on Wednesday the U.S. ‌Food and Drug Administration had granted marketing au

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced that the U.S. Food and Drug

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

CNBC's Jim Cramer urged investors to expand their portfolios beyond the market's hottest AI winners.

IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-wei

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approac

SOXX dips into a bear market

PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yie

IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's co

Johnson & Johnson JNJ announced robust second-quarter 2026 results on July 15, beating estimates for

Bartlett and CO. Wealth Management LLC lessened its stake in Johnson and Johnson (NYSE: JNJ) by 4.6%

Dorsey Wright and Associates boosted its stake in Johnson and Johnson (NYSE: JNJ) by 48.4% in the fi

Clifford Swan Investment Counsel LLC cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 1

California Public Employees Retirement System lowered its stake in shares of Johnson and Johnson (NY

The healthcare giant is on track to report full-year revenue of more than $100 billion. The company

The three biggest US pharma names by market cap trade at very different setups right now: Johnson &

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is a stock built to be owned for decades, not tr

Forty three Eighteen Advisors LLC bought a new position in Johnson and Johnson (NYSE: JNJ) in the fi

Hamilton Point Investment Advisors LLC increased its stake in Johnson and Johnson (NYSE: JNJ) by 6.7

Financiere des Professionnels Fonds d investissement inc. cut its holdings in shares of Johnson and

Bessemer Group Inc. lessened its position in Johnson and Johnson (NYSE: JNJ) by 30.0% during the fir

Gerald Baker Financial Group LLC acquired a new position in shares of Johnson and Johnson (NYSE: JNJ

Johnson and Johnson (NYSE: JNJ - Get Free Report) has been assigned an average recommendation of "Mo

Most investors chase the biggest yield they can find, but the portfolio that actually grows your inc

July tests investor conviction. From the 2011 debt-ceiling standoff to the 2022 inflation shock, sum

Lifelong learning sounds like a noble habit until you price it out across decades and realize it beh

On Thursday, July 16, during the broadcast of Mad Money , Jim Cramer pushed back on the market's pun

Four thousand dollars a month can cover a paid-off house, groceries, utilities, insurance, and modes

JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Fin

Eli Lilly's first venture into psychedelic medicine, a takeover of AtaiBeckley worth up to $3.8 bill

Johnson & Johnson posted strong Q2 earnings. Sales of its NMDA receptor antagonist, called Spravato,

Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform

Few things ruin a Saturday morning faster than the words "your timing chain is going." Car repair bi

UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp d

Johnson & Johnson (NYSE:JNJ) shares rose in early trading on Thursday, after the company reported up

The reasons why RBC Capital Markets maintains its stock rating.

RBC Capital analyst Shagun Singh reiterates Johnson & Johnson (NYSE:JNJ) with a Outperform an

Johnson & Johnson raises its 2026 outlook after Q2 earnings and revenues beat estimates, driven by I

A report on July 15, 2026 shows that Representative Thomas Kean from New Jersey sale stock in Alphab

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight

One generates steady cash flow with a lower valuation; the other is growing at 45% but carries highe

Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight

The transaction strengthens DePuy Synthes’ Spine portfolio and expands its position in the rapidly g

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced with TIME the la

RAYNHAM, Mass.--(BUSINESS WIRE)--DePuy Synthes, a global leader in orthopaedic technologies and solu

Twenty thousand dollars a month in dividends means $240,000 a year that has to arrive whether the ma

Ora Banda Mining Ltd (ASX:OBM, OTC:ESGFF) has closed FY2026 with record quarterly gold production, s

Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Belo

Many traded out of the pharmaceutical sector mainstay to leave it with a nearly 3% loss. While the c